Moser Wealth Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,452
| Closed | -$131K | – | 169 |
|
|
2024
Q4 | $131K | Sell |
1,452
-225
| -13% | -$20.3K | 0.07% | 81 |
|
|
2024
Q3 | $166K | Hold |
1,677
| – | – | 0.09% | 81 |
|
|
2024
Q2 | $155K | Buy |
1,677
+22
| +1% | +$2.04K | 0.08% | 81 |
|
|
2024
Q1 | $157K | Buy |
1,655
+25
| +2% | +$2.37K | 0.09% | 79 |
|
|
2023
Q4 | $146K | Sell |
1,630
-411
| -20% | -$36.7K | 0.09% | 74 |
|
|
2023
Q3 | $149K | Buy |
2,041
+193
| +10% | +$14.1K | 0.1% | 71 |
|
|
2023
Q2 | $154K | Buy |
+1,848
| New | +$154K | 0.1% | 70 |
|
|
2022
Q4 | $127K | Buy |
1,527
+100
| +7% | +$8.3K | 0.1% | 72 |
|
|
2022
Q3 | $113K | Hold |
1,427
| – | – | 0.09% | 74 |
|
|
2022
Q2 | $106K | Hold |
1,427
| – | – | 0.08% | 75 |
|
|
2022
Q1 | $128K | Buy |
1,427
+782
| +121% | +$70.1K | 0.08% | 74 |
|
|
2021
Q4 | $72K | Buy |
645
+100
| +18% | +$11.2K | 0.04% | 88 |
|
|
2021
Q3 | $69K | Buy |
545
+493
| +948% | +$62.4K | 0.04% | 88 |
|
|
2021
Q2 | $7K | Buy |
+52
| New | +$7K | ﹤0.01% | 118 |
|